Evidence map›Paper›PMID 35975040›Full record

ArticleRSC advances2022

Mamo Gebrezgiabher, Sören Schlittenhardt, Cyril Rajnák, Juraj Kuchár, Assefa Sergawie, Juraj Černák, Mario Ruben, Madhu Thomas, Roman Boča

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in RSC advances, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. RSC advances · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Mamo GebrezgiabherDepartment of Industrial Chemistry, College of Applied Sciences, Nanotechnology Excellence Center, Addis Ababa Science and Technology University Addis Ababa P.O. Box 16417 Ethiopia madhu.thomas@aastu.edu.et.ORCID https://orcid.org/0000-0003-3758-3986
Sören SchlittenhardtInstitute of Nanotechnology, Karlsruhe Institute of Technology Hermann-von-Helmholtz-Platz 1 76344 Eggenstein-Leopoldshafen Germany.ORCID https://orcid.org/0000-0002-9294-0272
Cyril RajnákDepartment of Chemistry, Faculty of Natural Sciences, University of SS Cyril and Methodius 91701 Trnava Slovakia roman.boca@ucm.sk.ORCID https://orcid.org/0000-0003-2173-6220
Juraj KuchárDepartment of Inorganic Chemistry, Institute of Chemistry, P. J. Šafárik University in Košice 041 80 Košice Slovakia.ORCID https://orcid.org/0000-0003-3473-7150
Assefa SergawieDepartment of Industrial Chemistry, College of Applied Sciences, Nanotechnology Excellence Center, Addis Ababa Science and Technology University Addis Ababa P.O. Box 16417 Ethiopia madhu.thomas@aastu.edu.et.ORCID https://orcid.org/0000-0002-1604-7992
Juraj ČernákDepartment of Inorganic Chemistry, Institute of Chemistry, P. J. Šafárik University in Košice 041 80 Košice Slovakia.ORCID https://orcid.org/0000-0002-8143-1368
Mario RubenInstitute of Nanotechnology, Karlsruhe Institute of Technology Hermann-von-Helmholtz-Platz 1 76344 Eggenstein-Leopoldshafen Germany.
Madhu ThomasDepartment of Industrial Chemistry, College of Applied Sciences, Nanotechnology Excellence Center, Addis Ababa Science and Technology University Addis Ababa P.O. Box 16417 Ethiopia madhu.thomas@aastu.edu.et.ORCID https://orcid.org/0000-0003-4352-5360
Roman BočaDepartment of Chemistry, Faculty of Natural Sciences, University of SS Cyril and Methodius 91701 Trnava Slovakia roman.boca@ucm.sk.ORCID https://orcid.org/0000-0003-0222-9434

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The

Identifiers

PMID35975040
PMCPMC9350813

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.